Inovio Pharmaceuticals, Inc.INONASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-112.40M
↑ 17% above average
Average (9y)
$-134.86M
Historical baseline
Range
High:$-34.28M
Low:$-301.22M
CAGR
+14.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-112.40M | +21.9% |
| 2023 | $-143.94M | +46.2% |
| 2022 | $-267.57M | +11.2% |
| 2021 | $-301.22M | -142.8% |
| 2020 | $-124.08M | -11.7% |
| 2019 | $-111.11M | -18.1% |
| 2018 | $-94.09M | -12.5% |
| 2017 | $-83.64M | -9.7% |
| 2016 | $-76.24M | -122.4% |
| 2015 | $-34.28M | - |